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PART I 
L I T E R A T U R E 
SURVEY 
For rna.n;;r yee.rs, scientists a.na. clinicia.ns r...a.ve been searching· for an 
effective agent capable of blocking resp onses to adrenergic nerve ~nd 
a.<lrem;!.l a.ctivi ty. Adrenerg ic nerves are those p ostganglionic nerve s of 
the sympathetic ner1tous system t·rhich tra.nsmi t impulses and elicit res-
p onses through the medi ation of a chemice.l agent , ep inephrine or sympa-
t hin . There are a number of clinice.l entities uhi ch involve the hyper-
activity of the sympatho-aclrena.l system. The successful trea.tment. of 
these requires a.ctive drugs vrhich specificall y diminish or a.bolish the 
discrete responses of smooth muscle cells to circulating epinephrine or 
sympathomimetics, and. sympathetic nerve stimulus . Adrenerg ic blocking 
drugs find experiment a l use in enhancing the knowledge of function of 
actrenerg ic nerves and. i n explaining the a.etails of the meche..nisms inv-ol-
ved. They ha.ve also been used in dif.JEnostic \vork to determine the extent 
to uhich hY:r,leractivi ty of the adrenals ha.s been involved in clinice.l 
illness . 
1. 
There are specific requirements for these adrene r g ic blocking agents 
1>.rhich must be satisfied i f they are to have lileclical ap~1lications . They 
must be highly specific with preferentia l antagonism of resp onses to 
s;>-1!lpe.thomimetic and aclrenerg ic nerve stimulation. The blockade p roduced 
must be eff ective against strong adrenerg ic stimulation and. be mainte.ined 
ov-er a. p rolong ed period. of t i me . The effective ad.renerg ic blocki~; dose 
of the ag ent must be sma.ll in relation to i t s toxic dose , i.e. the thera-
p eutic index must be hi gh . The poss i bility of a, specific antidote to the 
toxic effects of the adrenerg ic blocking agent might a l so be included in 
any list of requirements . 
2 . 
· ~drenergic blocking action has been primarily determined by the effect-
iveness of an agent to diminish or reverse the p ressor respcnse of the 
dog a.nd cat to injected epinephrine or reflex sympathetic nerve stimu-
lation. Loe\·1 cautions ( L~J ) that this phenomenon is not ad.eqm:tte :proof 
that adrenergic nervous activity is significantly blocked_. It a:9:pears 
that the close of all the adrenerg ic blocking e..gents investigated t:.rhich 
is required to diminish or reverse the pressor response to epinephrine 
is only one th:i.rd_ t:b..B.t required to a ctually decrease adrenerg ic nerve 
a.ctivity. Thus, to be considered an authentic adrenergic blocki!l?-' a.gen t 
any drug must be sho\m to climin iSl'l ep inephrine- and. adrenergic nerve-
i nrluced. responses of smooth muscle or other organs of the body, isolated. 
or in vivo. This has been a.one for most of the blocking agents investi-
~atect , but a g ret'l.t deal of variance exists a.mo11_g the different groups 
regarding the -potency, specificity, and the clinical usefulness of the 
a.drenalin anta,.gonism. 
The adrenerg ic blocking agents appear to exert hm distinct ty-pes of 
blockade. Nickerson ( .57 ) labels these the 11 equilibriumll and llnon-equili-
brium11 or l1Dibemunine-like 11 types . N-( 2-chl oroethyl)dibenz;-.rlamine, (Diten-
e.rnine) , a member of the f.»· -haloalkyla.ni ne series of adrenergic blocking 
drug s, produces a blockade Hhich is slm,.r in onset. p resumably due to in 
vivo forma.tion of active intermectif'.tes necessary for the adrenergic 
blocking activity, but once established is complete ancl irreversible . It 
is of long duration ancl no increase in aclrenerg ic stimulation "~>Till over-
come it. A comp etitive e._quilibri Ulll bet, . ,een epinephrine and Dibenamine may 
exist \·!hile the block is being established, but a state of 11 non-equilibrium11 
occurs vri th the comple t e bloc:~acte. Other series o:L' adl'energic blockiJ."'_g 
a..gents exhH>i t a che.ra.cterlstic competitive a ction throughout a blockade. 
A relatively constHnt ratio of stimulus and blocking cl:rug vlill produce 
a constant reaction over a vride r8..nge of concentrations . The blockade is 
thus easily overcome by increased doses of the syrn:pathomh1etic agent . 
This "equilibrium" type blockade is usue.lly of more trl\.nsient natu.re 
and. less specific in action . 
The rationale of adrenergic blocking a.cti ri ty has not been substa.ntially 
estal)lished. There are Elany theories concerning the mechanism of action 
of the P.gents \·rhich p rocluce a.n equilibrium type blocka.cle . Receptor sub~ 
3tances, identified as those cellular factors involved in ac tivation by 
a spec ific agent, have been postUlated ( .5 ,5.5 ,57,) . The nature of these 
is unknown, but they eviclently account f6r the e.bili t y of the cells to 
exrdbi t characteristic responses to various stimula.ti 1g agents . The I'I.Ctive 
clestruc tion of epinephrine, the alteration of the permeability of the 
smooth muscle cells to sympathin , the destruction of the contractile 
meclw.nism of the cells, and the inhibi t ion of release of chemica l mecL-
ie.tor follot!ing nerve stimulation , :b..ave e.ll been eliminated as possible 
ex:yla.nations of the reporJced adrenerg ic blocking a.ctivi ty ( .56 ,57,) . :By 
decluction, these agents have l1een preswned to act by blocking some essen-
tial steps in the ~pro sess o'f ;,t imula.tion of smooth l!lUSCle cells occurrino 
subsequent to penetration of the syrn:pathoL'lirnetic aFent to the site of 
a ction . Finally, it is postulated the,t a,clrenergic blocking action chem-
icall ;,• must consist of a cl..isru.:ption of essent ial enzyme systems necessary 
for the normal res~oonse of smooth muscle to epinephrine compounds ( 28 ) • 
f> - haloalk".[lamines 
The most recently dicovered adrenerg ic blocking agents a re the ft- halo-
a llc-yl a.mines. They appear to b.B.ve advanta.ges a s sympa.tho-aclrene.l blocking 
agents e.s they p ossess the ·pro:perties of SJlecif:i.ci ty, potency, and 
:prolongec_ a ction. N-(2-ch.lo roethyl) d ib enzyl runine,Dibenf>..mi ne , "ras the 
first and most thorou,:;hly studied clrug of the s eries, but other members 
of the gro;_1~) appeB.r to exert more sp ecif ic and more potent adrenerg ic 
blocking a ction. These a~ents apparently p roctuc e t he non- equilnriTlln 
t ype of blocka cte .?.nd , thereby, differ frm-:1 other adrenergic block i ng 
conroounds . 
Accor3.ing to Nickerson ( 57 ,58 ,) the block ing a ction of Dibenam n e 
develop s i n t'vo stages: first, a :p r olongecl state of competitive action 
exists 11 et\-_reen Dibenamine and ep i nephrine , during v!hich time increased 
doses of epinephrine vrill diminish the effectiveness of the b lockade; 
4. 
then , chemical m1ion behreen Dibenamine and an e:pinephrine-sensi tive 
recept or su~stance is postul a ted. Sane substance on or in the cell, 
essentia l f or a resp onse to excitation b y a drenergic comp ounds , ma,y be 
ina ctiva ted. Perr..ap s a simple enzyme system is . involved. A direct coupling 
of Dibenamine to tissue constituents, which is de!:J enctent upon i_l!___y:_:l,_yo 
fori a tion of intermedia te transformation p roducts capable of formi ng 
stable cova l ent bonds , is inclic0.ted. Thiosulfa te uill rea ct corn~etitively 
1-ri t h t hese transformation p r oduc ts, and if adJ!linistered =r;Jrior to Diben-
2.mine, ~;Jill inhibit the bloclmde. The adrenerg ic antagonism of Dlbenarnine 
is slat·r in onset, but once adeqllJ:tte blockade has been established even 
massive closes of ep inephrine \Jill not surmount the barrie:t . In adc1_i tion. 
this blocka.d.e , in contrast to tb.B.t of many other agents, is not cocaine 
sensitive , i.e. \'Jill not b e d i minished. due to the ep inephrine :potentia-
tion this substance normally produces . Thus, the Dibena.mine- ty-_pe blockade 
is P-. :orolon-~ed non-eauilibrium adrenergic antag onism proclucecl thro~h 
i ntermedi ates "I'Thich react ~-lith thiosulfate . 
Certain relntionship s exist lJehreen the chemica l a.nd the -:?h?..rnacolo.gica l 
.?.ctbri ty of the P -haloa lkylP.mines vhich are of importance . Nickerson 
reports certain specific chemica l configurations vrhich a re necessP~ry fo r 
the high de::sree of pharmacolog ical SJ!ecifici ty of t hese drut; s ( 57 ,.58, ) • 
Th e corrmound must be a tertiary amine, must inclucle at least one/ -fia lo-
alk-.flamines .;; rou.:p cap.?.ble of formil\~ active intermecl.iA.te ·· -:?roducts , and 
it ::Jus t inclucie an unsaturated ring structure , sat isfying certe.in steric 
requirenents, •·rhich is a1J le to st?..bilize the intermediates formed. Excep-
tions to these requirements have been reported recently by Kervrin et a.l . (30 ,31,). 
The ~ -haloalkylamine series specifically blocks certain excitatory 
res~oonses to e:9ine:phrine and other sympathomimetic amines, less markedly 
ai'fecti:n.,s sympathetic nerve stimulation . These amines e:cert very little 
ac tion themselves on smooth muscle of the uterus, intestine , nictitating 
membrane , a nd vascular system, but do act as bronchoconstrictors of the 
isolated .. guinea pig lung ( 72, 73,) and cardiac depressors on the isol-
ated m8Jlli!18.l ian he:irt ( 2,3,) . The p rimary side effects of the g rou;_o 
are local tissue clama.ge after su'ocutaneuus , intraperi tonea.l, or intra-
nusc-.l.lar administrat ion, a nd stimulat ion of the centr2"l nervous s~tstem. 
In e~oeriments on isolated tissue, Dibenamine, even in smqll doses 
( 1:1.000 , 000 - 1:15,000,000 ) inhibits most excitatory response s to 
epinephrine. It has been fOi .. md to diminish, block a:nd. even reverse the 
ep ine1Jl1rine-ind.uced contract ion of the non-p regnant rabbit uterus ( 54 ) • 
Presumably , the ~ -haloalkylamines block the p ositive action of epinephrine" 
,. 
o. 
on smooth muscle, unmasking the negative and inducing a reverse reaction. 
:Oibenamine diminishes t he vasoconstrictor action of ep inephrine, and .r:1ore 
eff ective}' that of norep inephrine on the perfused vessels anc1.. the hinctlimbs 
of the rabbit ( 79 ). The smooth muscle of the isolated guinea p i g seminal 
vesicle rea cts to sympathomimetic agents \-lith a ma.rkeCl. contraction , \·rhich 
is rea.diJ.y d iminished by Diben8..rnine ( 79 ) • The resp onse to norepine~9hrine 
is antagonized by smaller doses of the adrenerg ic blocking drug. Diben-
arai ne blocks the response of the nic titating membrane of the ca t more 
effectively ano. rap idly ;tr:r..an the res~.1onse to sym~)athetic nerve activity 
( 1,56,) • . A.lso, a partial reduction of the reaction of this tissue to 
histamine has been observed., t·rhich is evidence of the vreak a.ntihistaminic 
property of Dibenamine. 
The f -haloalkylamines do not alter the inqibitory responses of smooth 
m11scle to epinephrine. The adrenerg ic relaxation of the intestine of the 
rabb i t , guinea p i g , and rat, and inhibi tion of the non- pregnant cat uterus 
are not affected by the same concentrat ions re ~uired to i~~ibit excita-
tory responses ( 57 ). De Schaepclrijver ( 72,73,) has reported that Dib-
enami ne, a bronchosonstrictor itself, t·dll reverse the bronchodilator 
effec t s of norepinephrine and epinephrine . The report does no t g ive a 
sufficiently cletailed account of dosag e and ma,gni tude of res:<:lOnse for 
definite conclusions. 
The ?. -chloroethyle .. mi nes act directly as depressors of the isol a t ed 
ra1)bit ancl dog heart. Cardioacceleration ancL positive inotro:;?ic response 
to e:pine:9hrine, even in larg e doses and 1:lith lon.-"S duration of a~glication, 
are not altered ( 2,J,). Dibenamine \·rill effectively block the epinephrine-
• 
induced auricular fibrillation of the decentralized dog heart(3). In 
unexplained contrast to the lack of action on the excitatory responses 
of the mammalian heart to epinephrine, the e -haloalkylamines do 
block and even reverse the adrenergic chronotropic action of the iso-
lated frog heart( 64 ). This action is comparable to that of the ergot 
alkaloids on this organ and will be discussed in that section. 
7. 
Thus, Dibenamine seems specifically to block adrenergic a~citatory 
effects on smooth muscle and to have no substantial action against epine-
phrine-induced inhibitory or cardiac activity. The other f -:P..aloalkylamines 
parallel those actions of Dibenamine, although many of them are more 
potent adrenergic blocking agents. This is true of 2-(2-biphenylyloxy)-
21-chloro-triethylamine( SY-8 ), N-(2-chloroethyl)-N-ethyl-1-naphthal-
ene-methylamine (SY-14), N-(2-bromoethy1)-N-ethyl-1-naphtha1enemethyl-
amine.HBr (SY-28) and N-(2-(2-biphenylyloxy)-ethy1)-N-(2-chloroethyl) 
butylamine (SY-30). Some of these agents, primarily SY-14 and SY-28 
exert marked ant ihistaminic activity in addition to their highly effective 
adrenergic ant agonism ( 39,42). Atropine-like ability to diminish res-
ponses to acetylcholine is also found in some f; -haloalkylamines which 
limits their specificity. Di beaamine and N-et hyl-N-(2-chloroethyl)benz-
hydrylamine (SY-2) appear to exhibit the least tendency towards these 
properties and are considered the most specific adrenergic bloclcing agents 
of the group. The further activity of SY-2, SY-8 and N-ethyl-N-(2-chloro-
ethyl)-9-flourenamine (SY-2l) is discussed i in .the experimental section 
of this paper. N,N-dimethyl-2-chloroQ2-phenylethylamine (SY-93), a 
recently developed member of this series, rills the Klosest structural rel-
8. 
ationship to adrenergic stimulating compounds, of all the blocking agents,l8). 
SY-93, like Dibenamine, may be prevented from producing adrenergic blockade 
by the previous administration of thiosulfate. SY-93, however, is not 
an exceptionally potent or specific agent and the adrenergic blockade is 
of short duration. 
Ergot Alkaloids 
The natural ergot alkaloids were the first agents which were demonstrated 
to produce a true specific adrenergic blockade. Dale in 1906 ( 17 ) reported 
classical studies using partially purified ergot alkaloids and his basic 
observations have since been extended and confirmed by others. More recently 
the natural ergot alkaloids have been broken down into distinct components. 
The primary agents in this group are ergotamine, ergotoxine ( a complex of 
three alkaloids: ergocornine, ergocristine, and ergokryptine ) ru1d ergo-
novine. The latter compound exhibits marked oxytoxic activity, but no 
adrenergic blocking ability ( 75 ). The other agents all exhibit direct 
stimulating action on vascular and visceral smooth muscle, are quite toxic, 
and induce varying degrees of adrenergic blockade. Recently, the less 
toxic dihydrogenated derivatives of the ergotamine and ergotoxine groups 
have been found to exert very little stimulating action on smooth muscle, 
and yet more potent adrenergic blocking activity ( 69,70,). 
The ergot alkaloids and their dihydrogenated derivatives produce a 
complete adrenergic blockade, which is slow in onset and of relatively 
short duration. It is effective against strong adrenergic stimuli,while, 
with the exception of the f -haloalkylamines, other ·series of adrenergic 
blocking agents are not. The ergot compounds do not exhibit an absolute 
degree of specificity, a s the high molecular alkaloids have been reported 
to have a '\'leak, characteristic anti histaminic property ( 8 ) , and to 
potentiate some cholinergic responses ( 57 ). The do block most excitatory 
adrenergic effects on smooth muscle and some epinephrine-induced inhibitory 
effects. However,these responses are often complicated by the stimulating 
action of the natural alkaloids, which frequently is evident with doses 
smaller than those required to produce adrenergic blockade. 
In experiments using isolated tissue preparations, the natural alkaloids 
themselves, promote the natural rhythm and inc~ease the tone of the uterus 
of the non-pregnant rabbit ( 12,67,69,) and cause contractions of isolated 
stoma ch strips of the dog, cat and rabbit ( 46 ). They have little direct 
action on the uteri of the guinea pig and r at and on intestinal muscu-
lature of the rabbit, cat and guinea pig ( 49,52,67,77,). The dihydrogen-
ated alkaloids exhibit no direct effect on any of the isolated smmoth 
muscle preparations used, other than a tendency to inhibit the natural 
rhythm of the rabbit uterus ( 10,69,70,71,). 
On the isolated uterus of the rabbit and pregnant cat and guinea pig, 
the excitatory action of epinephrine is totally or partially inhibited 
by ergotamine. The dihydrogenated derivatives exertr: twice as marked 
inhibitory action on the epinephrine-induced contraction of the non-
pregnant rabbit uterus and likewise diminish the spasmogenic action of 
ergotam:i,ne and ergono vine ( 67,69,77,). These blocking effects are of 
short duration and the original epinephrine-induced excitatory response 
is readily restored. The seminal vesicles of t ne guinea pig have been 
found to be extremely sensitive to the adrenergic blocking action of ergot 
preparations ( 6,12,). Ergotamine tartrate itself causes no i mmediate 
10. 
direct change in the activity of the tissue, but in a concentration of 
1:)0,000,000 produees partial or total inhibition of the contraction in-
duced by a 1:1,000,000 dose of epinephrine. Even massive doses of epine-
phrine will not overcome this block ( 6 ). The dihydrogenated alkaloids 
are seven times more potent than ergotamine in this blocking action ( 12, 
70,71,). Rothlin and Brugger, working vli th both the isolated guinea pig 
seminal vesicle ( 12 ¢, and the rabbit uterus ( 69 ), report the antag-
onizing potency against epinephrine-induced contractions, in decreasing 
order as dihydroergokryptine, dihydroergocrittine, dihydroergocornine,and 
dihydroergotamine. 
Epinephrine causes cont ractions of the isolated stomach strip of the 
dog, rat and rabbit and ergotamine reportedly inverses this action to a 
marked inhibition of smooth muscle activity ( 46 ). 
In experiments with isolated vessels of the perfused ear ~~d hind 
extremities of the r a bbit ( 79 ), the vasoconstrictor action oe epineph-
rine is inhibited by ergot alkaloids. The excitatory responses of the 
isolated mammalian heart to epinephrine are not affected by the ergot 
preparations and these epinephrine antagonists have no direct action on 
this organ ( 10, 71,). The isolated frog heart presents a paradoxical 
situation. Bmth the ergot alkaloids and t he (0 -haloalkylamines effectively 
block the positive· chronotropic effects of epinephrine on the heart of 
the winter frog, but not of the summer frog. The positive inotropic res-
ponse of the heart to epinephrine is not blocked under any conditions. 
This is reported and explained by Nickerson and Nomaguchi ( 61 ) a s an 
effect which is under the control of the anterior pituitary. Epinephrine 
presumably releases energy for the production of tachycardia in the winter 
frog heart by one mechanism and in the :Summer frog heart by t wo, only one 
11. 
of which may be antagonized by the blocking agents. Both mechanisms are 
independent of energy sources required for inotropic responses. 
The actionof the ergot alkaloids on epinephrine-induced inhibitory res-
ponses is more variable. The relaxing action of epinephrine on the rat 
uterus and t he colon of the cat and guinea pig is not influenced by ergot 
alkaloids ( 49,68,77,). The antagonism between ergot alkaloids, especially 
dihydroergotamine, and adrenalin is easily demonstrable on the rabbit ileum 
( 52 ), where these adrenergic blocking agents readily inhibit epinephrine-
induced relaxation of the intestine ( 70,71,). However, Nickerson ( 57 ) 
points out that intestinal smooth muscle is not as suitable a test object 
as vascular and uterine tissue for study of adrenergic i nhibitory responses. 
The ergot alkaloids are known to potentiate choline~gi c responses. As there 
are a great number of parasympathetic ganglia in the wall of the i ntestine, 
it is difficult to determine vthether changes in epinephrine-induced re-
laxation of t he intestine are anti-adrenergic in nature. Since intestinal 
smooth muscle is t he only isolated organ effectively demonstrating any 
antagonism bet\veen ergot and ad renergic inhibitory activity , these results 
are not conclusive enough for evaluation. In contrast, the blockade of 
excitatory effects of epinephrine on many isolated organs has been sub-
stantially established. 
Benzodioxanes 
The benzodioxane derivatives are synthetic adrenergic blocking compoun ds 
vthich v1ere first studied by Fourneau in 19)). Piperidinomethyl benzodiox-
ane ( 9) )F ~'~~d diethyl-methyl benzodioxane amine ( 88)F ), are of prin-
ciple interest in this series. The group ~s not homogenous in its adren-
ergic activity as all the agents do not exhibit comparable adrenolytic 
and sympatholytic properties. The adrenergic blocking activity of some 
members of the group is confined primarily to action against responses 
to circulatreng epinephrine ( 9?5F ). Others ( 88)F ) exhibit ~~ ability 
to diminish the effects of both circulating sympathomimetics and sympathe-
tic nerve activity, although the latter always to a le sser degree. 
The anti-adrenalin action produced by the benzodioxanes is of the equi-
librium type; a 1.,reak blockade of short duration. This type is readily 
overcome by increased doses of epinephrine or diminished by previous ad-
ministration of cocaine, an epinephrine potentiator. There is some evi-
dence,in vitro, that 955F may owe part of its blocking action to an ability 
to facilitate the destruction of epinephrine. Morrison and Lissak in 1958 
( 51 ), reported that the inactivation of epinephrine proceeded three 
times more rapidly in solutions \vi th 955F than in solutions "VIi th epine-
phrine alone. They account for t he epinephrine-reversal· of blood pressure 
and decrease in smooth muscle response to an increased ina ctivation of 
epinephrine in the blood before reaching the receptor cells. The chemical 
mediator liberated by adrenergic nerve stimulus would endure a shorter 
expo sure to 955F and , therefore, its activity \•rould not be di minished to a 
comparable degree • . These observations have not, to my knowledglll ,been cor-
roborated, and there is more evidence that the dioxanes do exhibit a block-
ing action more comparable to that of yohimbine and the other equilibrium 
blockade producers~ 57 ). 
The benzodioxanes block most adrenergic excitatory effects on vascular 
and visceral smooth muscles and glands, and have also been reported to dimi-
nish some adrenergic inhibitory responses. The action of t he se agents on 
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isolated tissue is variable. Both 933F and 88)F by themselves exhibit a 
marked amount of exci tatory:-acti vi ty on smooth muscles, especially the 
uteri ofmanw species and the denervated nictitating membrane of the cat. 
The pregnant and non-pregnant uteri of the guinea pig , rabbit and cat all 
react to both 933F and 88)F by an increase in tonus vrith lo\"T doses, and 
marked contractions followed by contracture in higher doses ( 16 ). These 
stimulating effects decrease the accuracy of the adrenergic blocking results 
which have been reported. 
933F reportedly reverses the motor excitatory action of epinephrine 
on the uteri of the rabbit and the pregnant cat ( 16 ). In the rabbit, 
88)F also causes a reversal of contraction induced by a vteak dose of epi-
nephrine, but a stronger dose overcomes this blockade. 933F is found to 
markedly decrease the retracting response to epinephrine and sympathin of 
the denervated nictitating membrane , but these results are complicated by 
the action of 933F itself on this tissue ( 57,64 ,65,). It is reported to 
cause a persistent moderate contracture in the denervated, and thus sen-
sitized, nictitating membrane, but has no action on the non-denervated 
tissue. 
The inhibitory effects of epinephrine a re not as consistantly diminished 
by the benzodioxanes. The epinephrine-induced relaxation of the uteri of 
both non-pregnant cat and guinea pig is reportedly diminished by 933F ' 16). 
88)F has not been shown to produce any antagonism. to the response of epi-
nephrine on t hese tissues. The Ji.m.hibition of the rabbit intestine by epi-
nephrine was reported ( 26 ) to be prevented, Sl'ld the diminished tonus even 
increased by large doses of 88)F,( 1:4,000)against epinephrine(l:200,000}. 
The relaxation of the guinea pig intestine by epinephrine was reduced,sup-
presaed, or even inverted by 93)F. In the dose required, hovtever, this com-
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pound itself causes a marked decrease in the tone of the tissue, which may 
influence these results. 
Experiments concerning the action of the benzodioxanes on the i solated 
mammalian heart indicate that these compounds are effective as direct myo-
cardial depressants ( 45,47,62,). 933F directly depresses the isolated rat, 
guinea pig and cat heart in concentrations 11hich are lower than those re-
quired to change the respon se to epinephrine ( 45 ). The action of epine-
\ 
phrine and sympathin on the isolated frog heart is inhibited by 93)F. 
Among the benzodioxanes, therefore, there is quite a degree of variation 
in selectivity. 933F may exert adrenergic blocking activity on tissues which 
88)F will not affect ( i.e. non-pregnant cat uterus ). The dioxanes are 
reasonably specific ad renergic blocking agents in view of the fact that 
they do not block smooth muscle stimulation by barium chloride, and pit-
ui trin, but \vill diminish the re sponeeto epinephrine and other circulating 
sympathomi metics. 
Imidazolines 
2-benzyl-4,5-imidazoline•HOl : ,Priscol, is a synthetic compound chemi-
cally related to sympathomimetic amines and histamine. It has potential 
therapeutic value as a mild adrenergic blocking agent and active vasodi-
later. Rappears that Priscol produces an equibibrium type blockade against 
epinephrine-induced responses, which is of relatively short duration and 
greatly decreased by larger doses of the sympathomimetic. It blocks most 
adrenergic exciti tory effects on smooth muscle and glands, although the 
response to circulating epinephrine is diminished more readily than that 
to sympathetic nerve impulses. In addition , the i midazolines seem to have 
some direct effect on every tisuue in the body due to their non-specific 
histaminic, cholinergic and sympathomimetic properties ( 4 ). 
In experiments dealing with isolated tissues, Priscol is reported to 
block and reverse the excitatory action of sympathomimetics on vascular 
and visceral smooth muscle. The stimulating action of epinephrine on the 
rabbit uterus in vitro is readily inhibited and reversed by Priscol ( 4 ). 
The contraction of the isolated guinea pig seminal vesicle induced by both 
epinephrine and norepinephrine is diminished by Priscol, but not reversed (79). 
The blocking agent is reported to convert the vasoconstrictor action of 
epinephrine on the vessels of the perfused rabbit ear and hindlimb of the 
dog and rabbit to vasodilitation ( 22,50,). This would be expected, for 
Priscol iteelf is an active vasodilator and, perhaps, some of this reversal 
may not be due to a di~ect adrenergic blockade. 
Priscol is relatively inactive as an antagomist of adrenergi c inhibitory 
activity. The sympathetic relaxation of the non-pregnant cat and guinea 
pig uterus, and the intestine of the dog, cat and 'I'Thite rat, is not blocked 
by Priscol in any concentration ( 4,84,). The inhibitory response to epi-
nephrine on the rabbit intestine, however, is often blocked by Priscol, 
although the results are variable ( 4,22,). The inhibition of the gufunea 
pig intestine by epinephrine is somewhat prevented by Priscol, but to no 
greater extent than by histamine ( 4,22,). 
In each case, Priscol by itself acts as a stimulating agent. Priscol 
is cholinergic in nature when acting on the intact intestine since it it 
blocked by atropine ( 84 ). On some tissues it exhibits histaminic proper-
ties, as atropine does not prevent its stimulation of the isolated gut or 
isolated or intact uterus ( 4 ). It also potentiates the stimulating action 
of Ba012 , acetylcholine, pitressin and histamine ( 4 ). Thus, it is diffi-
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cult to evaluate the results when using Priscol since it either decreases 
the inhibitory action of epinephrine on the intestine, or exhibits intrinsic 
spasmogeni e potentialities. Priscol exerts no adrenergic blocking action 
on t he isolated mammalian heart, although it does produce vari a ble re-
~ponses itself. It is a cardiac stimulant, increasing the amplitude,coro-
nary flow, and cardiac output in the isolated heart of the dog and cat, but 
it produces the opposite action on the rabbit heart, depressing it. This 
depression is counteracted completely by atropine and epinephrine, although 
when given together in t he rabbit, Priscol acts synergistical l y with the 
sympathomimetic ( 4,22,). 
2- N,p-tolyl-N-(m oxy-phenyl)-aminomethyl -imidazol i ne, 0-7337, is another 
member of the imidazoline group with adrenergic blocking activity. The 
blockade it produces seems to be quite similar to that of Priscol as it 
is an equilibrium type of rel atively short duration, and is not effective 
agai nst large doses of epinephrine. It is reported to be a more potent 
adrenergic blocking agent than Priscol, but only slightly more specific (47,62,). 
It does not exhibit the stimulating activity on the guinea pig, rabbit and 
cat uterus which Prisbol induces, nor does it affect the isolated heart to 
any great extent. The inhibitory action of epinephrine on the uterus is not 
diminished, and the epinephrine-induced relaxation of the rabbit intestine 
is reduced or abolished only in extremely high doses. Ho'.<rever, 0-7337 is 
a very paten~ antagonist of the contraction due to epinephrine and norepi-
nephrine (§]£) t.he.-· i:so l ate'd semi nal vesicles of the guinea pig ( 79 ) • On this 
organ, it exerts more active adrenergic blocking activity t han Priscol, 
Dibenamine, the ergot alkaloids or yohimbine, and also shows indications 
of anti-acetylcholine and anti-histamine activity. 
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Yohimbine 
Yohhmbine is a naturally occuring alkaloid, obtained from a West African 
tree ( Yohimoene ), which has some adrenergic blocking action. It will 
block certain responses to circulating epinep1rrine, and with a two to 
five times greater dose will antagonize some excitatory effects elicited 
by stimulation of adrenergic nerves ( 57 ). It induces an equilibrium type 
of adrenergic blockade of short duration which may be overcome by increased 
doses of epinephrine. The pressor effects of epinephrine in dogs and cats 
is blocked and reversed by yohimbine, and it will decrease or annul most 
adrenergic excitat~ty effects on smooth muscle and glands. Stimulating 
effects of sympathetic nerve activity are less markedly antagonized, and 
inhibitory respon ses are slightly reduced. The adrenergic blocking activity 
of yohimbine on different organs varies greatly, and the effective block-
ade may be diminished by previous treatment with co caine . This was demon-
strated on isolated arterial strips ( 13 ) and is not unexpected since 
cocaine is known to potentiate the effects of epinephrine. It is not con-
sidered a specicfic adrenergic blocking agent as it reverses the pressor 
response to acetylcholine, potentiates histamine, diminishes the contraction 
response of the nictitating membrane to acetylcholine, CaCl2 and KCl, and 
has been reported to sensitize the perfused rabbit ear to epinephrine ( 57 ). 
It is more specific than the ergot compounds as it will not block the effects 
of BaCl2, pituitrin and histamine. 
The actions of yohimbine on isolated tissue has been investigated on a 
number of organs and species. Epinephrine exerts a motor action on the 
uterus of the rabbit which is effectively diminished by yohimbine ( 29 ). 
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The epinephrine-induced contraction of the denervated nictitating membrane 
is markedly decreased by yohimbine, and the contraction due to sympathetic 
nerve stimulation is also affected, although antagonized to a lesser 
degree ( 64,65,)· Chase and Yonkman and Young ( 13 ) report that although 
yol~bine exhibits no direct muscular effects, the constrictor action of 
epinephrine on isolated carotid arterial spirals of beef is slightly red-
uced and the rate of relaxation increased. Yohimbine, in a degree comparable 
to ergotamine, inhibits the constriction of the perfused hindlimbs of the 
rabbit induced by both epinephrine and noeep inephrine ( 79 ). The excitatory 
effects of norepinephrine and epinephrine on the guinea pig seminal vesicles 
are antagonized by yohimbine even in low concentrations, although not as 
effectively as by C-7337, Dibenamine or ergotamine. 
Reparts of re~urts concerning the action of yohimbine in blocking the 
inhibitory ·response of epinephrine are varied. Large doses have been demon-
strated to have a direct depressant effect on the rabbit and eat intestine, 
whereas small doses slightly stimula~e these organs ( 29,82 ,). Reduction 
or elimination of the epinephrine-induced inhibition of these intestinal 
segments by yohimbine has been reported ( 29 ). In the rat,yohimbine itself 
produces such a prolonged relaxation that no further results were obtainable. 
There seems to be a lack of sufficient data concerning the Yohimbine-indu-
ced blockade of adrenergic inhibitory response s and a conclusion based on 
these few reports is not possible. 
On the isolated heart yohimbine acts as a cardiac depressant in both 
the rabbit and the frog ( 14,29,). There ~ere no reported effects on the 
inotropic or chronotropic action of epinephrine on these tissues,which 
results correspond with those of other adrenergic blocking agents. 
Table I 
Properties 
Effectiveness 
Specificity 
Duration of 
Action 
Ty-pe of 
Bloclr..e.de 
Stimuli 
Pr::.mary 
Exci t e.tory drug 
Responses action 
to 
E-pinephrine 
Ac1ren-
ergic 
antag-
onism 
Su.rn:rnary of Properties of Selected Adrenergic Blocking Agents (:V.iodified from Nickerson,51 . ' 
(P - haloalkylamine s 
very high 
high 
histamine markedly 
blocked by some 
ace t ylcholine 
reduded by some 
very long 
non-eq_uilibrium 
sympathomimetic 
greater than 
sympathetic 
nerve activity 
little effect 
block or reverse on 
rabbit uterus 
block most other 
smooth muscle responses 
Ergot Al kaloids 
high 
DHA very high 
intermediate 
equilibrium 
sympathomimetic 
more than 
sympathetic 
nerve activity 
vasoconstriction 
naturals-strong ¢ of uteri and 
nict itating 
membrane 
DHA.- slight ¢ or 
l10 effect 
block or reverse 
u teri ,seminal ves-
icles and stomach 
-V or block vaso-
constriction rabbit 
Imitlazo 1 ine s Benzodim::anes 
lm1 - parasymlJatheti c 
histamine-like ¢ 
sympathomimetic 
relaxa tion 
intermediate 
equilibrium 
sympathetic 
more than 
sympathetic 
nerve acti'bity 
¢ uteri of 
many species 
C-7337 has 
no effect 
block or reverse 
uteri,block sem-
inal vesicles 
reverse vasocon-
striction 
short 
equilibrium 
sympathomimt3tic 
more than 
s;>"lllpathetic 
nerve activity 
¢ ra-bl)i t uteruEl 
¢ pregne..nt uteri 
of many species 
$?nictitating 
membrane 
933F block or 
reverse uteri 
883F no effect 
-tr nictitating 
membrane contr-
action 
Yohimbine 
short 
equilibrium 
sympathomimetic 
more than 
sympe.thetic 
nerve a.ctivity 
slightly 
relaxes 
smooth 
muscle 
-I,. smooth muscle 
nictita ting 
mem-brane and 
va soconstr-
iction. 
Tabl e I Cont inued 
Prpperties -haloalkylamines 
Primary 
drue; 
Inhib- act i on 
itory 
Res-
ponses 
to 
Epi ne- Adren-
:9hrine ergic 
8)1t aE;-
oni sm 
Primary 
drug 
Cardiac action 
Res-
ponses 
to Adren-
Epine- ergic mammal 
phri ne an tBg -
onism . ~ . . :;, _; 
f r og 
Side Effects 
little effect 
broncbnconstrictor 
lit t l e effect 
Cardi ac depression 
rate and am~Jli­
tude 
unaltered 
arrhythmi as 
prevented 
blocked. or reversed 
loca l ti esue dama~e 
¢ Sentral Nervous 
System 
Ergot Alkaloids 
no effect on 
i ntestine or 
nonp regnant ulberi 
of some species 
i nhibit or 
reverse intes-
tine and some 
uteri 
naturals-cardiac 
depression 
DHA no effect 
Imid. zolines 
¢ uteri and 
intestine of 
many species 
strong periph-
eral vasodili-
tation 
--V or block rab-
bit and guinea 
pi g i ntestine 
no effect on uteri 
r abbit heart depr-
ession , dog and cat 
strongl y ¢ 
C-7337 no effect 
unaltered or 
un.:'lltered potentie.te 
Benzodioxane s 
88JF 1 tone of 
r a-nbi t duodenum 
no other effect 
~or block non-
pregnant uteri 
of some species 
block rahbit 
intestine 
Cardiac 
depression 
unal tered 
arrhyt~~ias pr evented 
DHA unaltered 
naturals-blocked litt l e eff ect 
chron@t-rop.i e ;.but ·.:. ):;. .:: 
i nopropic unaltered 
st rong va so-
lUl i t1:1tion 
bmocked or 
reversed 
Key to abbrevi 2.tions : DRA-dihydrod.e riv8.tmves, ¢- stimulates, t - increases , -¥ -decre~:t.ses . 
Yohimbine 
slightly 
rel axe s 
smooth 
muscle 
intest i ne 
inhibited 
slightly 
Cardiac 
depression 
in dog 
and. rabbit 
unal tered 
arrhythmia s 
p r event ed 
blocl ed? 
local 
a.nesth8sia 
19. 
Literature Survey Summary 
To summarize; all of the adrenergic blocking agents investigated appear 
to be more effective against responses to circulating sympathomimetic 
mediators than against responses to sympathetic nerve avtivity. They all 
seem capable of blocking excitatory responses of vascular and visceral 
smooth muscle to epinephrine and sympathetic nerve stimulation of a large 
variety of organs and species. The P-haloalkylamines related to Dibenamine, 
especially SY-14 and SY~28, and the dihydrogenated ergot preparations are 
the most potent in this respeet. The adrenergic blocking agents are rela-
tively ineffective against adrenergic inhibitory responses with the excep-
tion of dioxanes, ergot alkaloids and Priscol, which reportedly block 
inhibitory responses to epinephrine on isolated organs of selected species. 
These inhibitory antagonisms are not proof enough for any conclusion as there 
are additional factors in most cases which might invalidate results. 
Evaluation of results is complicated in some organs due to the presence 
of ganglia and the effects of non-adrenergic stimulation. The drugs·which 
induce blockade of relaxing responses due to epinephrine do not exhibit 
any high degree of specificity of action and readily produce undesirable 
side effects. No true inhibitory action has been blocked on vascular or 
uterine smooth muscle, the more suitable test objects for testing antag-
onism to sympathomimetics ( 57 ). Likewise, no true blockade of adrenergic 
inhibitory responses has been demonstrated by P -haloalkylamines and yohim-
bine i•Thich exert the most specific adrenergic blocking activity.The reactions 
of isolated tissues are generally comparable to those dbse':tved in the intact 
animal, but the resul ta are not ah1ays directly transferable to in vivo 
preparations. Therefore, reactions of different species, activating agents, 
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and tissue preparations in situ and in vitro, should be adequately studied 
in parallel to warrant any significant conclusions. 
The -haloalkylamines seem, of all t he compounds studied, to fulfill 
most satisfactorily the requirements for an effective adrenergic blocking 
agent. If administered via appropriate routes, they are not highly toxic. 
They are reasonably specific and potent antagonists of adrenergic excitatory 
responses, and the blockade t hey produce is complete and irreversible. 
PART II 
EXPERI MENTAL 
SECTION 
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The ~-haloalkylamines appear to be the most promising of the newer 
adrenergic blocking agents in regard to practical therapeutic use. Several 
members of the series possess strong antihistamine and anti-acetylcholine 
properties, which decrease their usefulness in clinical cases concerned 
specifically with hyperactivity of the sympatho-adrenal system. It would, 
thus, be of value to determine, even qualitatively, the degree of specificity 
and t he relative potency of antagonism exhibited by several more active I 
adrenergic blocking agents of the ~ -haloalkylamine group. This paper 
reports results of an experiment concerned with the specificity and relative 
potency of selected members of this series with reference to their antag-
onism to the naturally occurtigg compounds, epinephrine, norepinephrine, 
histamine and acetylcholine,on the isolated seminal vesicle of t he guinea 
pig. 
The seminal vesicles of the guinea pig are elongated tubular structures, 
often with lobular protrusions. They consist of a thin wall of two layers 
of smooth muscle, an outer longitudinal and an inner circular, and of an 
enveloping fibrous muscular coat. They are innervated from both sympathetic 
and parasympathetic sources ( 80 ). 
These seminal vesicl es were chosen as test objects for qualitative speci-
ficity studies for several appropriate reasons. Most important, they react 
to all four agents used, epinephrine, norepinep~rine, histamine and acetyl-
choline,by a definite and comparable contraction. Most other smooth muscle 
organs react to sympathomimetics and histamine, for instance, in diametri-
cally opposite ways. It is difficult to compare accurately the specific 
antagonism of a drug towards these agents if i n one case a contraction and 
in the other relaxation of the organ is involved. Further, the guinea pig 
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seminal vesi t<iles have already been sho'l'm to be extremely sensitive to some 
adrenergic blocking agents. Rothlin in 1925 (67) sho'\'red for the first time 
the adrenalin inhibiting action of ergotamine on the isolated seminal vesi-
cles of the guinea pig, and determin~d that these teet objects showed for 
ergot alkaloids an essentially greater susceptibility than the isolated 
rabbit uterus and small intestine. The results of this paper indicate that 
they are also relatively sensitive to the adrenergic blocking action of 
selected ~-haloalkylamines. 
The seminal vesieles serve as good test objects because they exhibit 
very little in~erent rhythmicity which mi ght complicate the interpretation 
of results of antagonism studies. The organs are easily removed intact 
vri thout evident damage, and they remain reactive for several hours. They 
do not appear to demonstrate such variability of action as does the iso-
lated uterus, as their physiological state and sensitivity to stimulating 
agents are not as dependent upon cyclic hormonal balances in the intact 
animal. Guinea pigs also have the advantage of being reasonably inexpen-
sive and easily obtainable experimental animals. 
Method 
The contractions of seminal vesicles of guinea pigs weighing )00-600 
grams ;-;ere studied using the modified Magnus method of recording the activity 
of isolated smooth muscle. The animals were killed by a blow on the head 
and the two organs were immediately extracted and placed in warm Locke 1 s 
solution. The whole organ was used intact, the proximal end of each vesicle 
being attached to the base of a glass tube, and the distal end to a recording 
/ 
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lever. Bacq (6) recommended expressing the contants of the vesicles if they 
were extremely full of seminal fluid. This was not often found to be neces-
eary, but occasionally either the base was n<ilt tied off tightly, or a small 
cut was made in the side of the proximal end close to its point of attach-
ment to the glass -tube. The first contraction of the vesicle to a spasmogen 
caused the outflo'I'T of the seminal fluid into the bath, which -vras then \'lashed 
out. 
The two seminal vesicles were placed in a smooth muscle bath of 100 cc. 
capacity which was in turn suspended in a tank of circulating warm \'later. 
The temperature vias thermostatically controlled, resulting in a nearly 
constant temperature in the smooth muscle bath of .39 ~ 0.50° C. Locke 1 s* 
solution for mammalian tissues was used as a nutrient fluid and was freshly 
prepared from stock solutions each day, the glucose being added separately. 
The solution was aerated \'Ti th a constant stream of 02 from the bottom of 
the bath which also served to dipperse the added drugs throughout the nut-
rient medium. 
The contraction of the seminal vesicles v;ere recorded on a slowly revol-
ving kymograph. Nearly isotonic frontal 1-rri ting lever.;, modified from Schild, 
were used, which magnified the contractions ten to eighteen fold. A constant 
load of 0.5-1.0 grams was maintained. When it was necessary to wash the 
tissues to remove an active drug, the Locke's solution was brmught in from 
the bottom and siphoned off the top of the smooth muscle bath. Thus, the 
organs were never directly exposed to air at an~ time. Some mixing took 
* The chemical proportions of the solution per 100 cc. were as follows: 0.015 
gms. of NaHC0.3, 0.9 gms. of NaCl, 0.042 gms. of Kal,O.Ol8 gms. of Ca012, 
and 0.1 gms. of glucose. 
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pl ace, but prior studies had determined that 3/4 of a minute of washing 
would remove all of the previous fluid from the bath. At t he end of t he 
experiment each vesicle was measured and weighed for po ssible correlation 
of size with activity. 
The primary compounds u sed for this antagonism study were epinephri ne, 
norepinephrine, histamine and acetylcholine. They are all naturally occurr-
ing substances of the intact animal and all induce a marked contraction 
of the guinea pig seminal vesicle. Dose response studies \'iere performed 
with epinephrine and norepinephrine to determine the range of activity 
of the two drugs. A dose was chosen which consistantly produced approxi-
mately 85% maximal contractions of the test organs,77). This was 200 meg. 
for both drugs, which resulted i n a final concentration of 1:500,000 in 
the 100 cc. smooth muscle bath. A dose of histamine was chosen which 
produced a 65% maximal contra ction (77). The dose used and the final con-
centrations of histamine diphosphate and acetylcholine chloride in the 
100 cc. smooth muscle bath was 400 mcg.(l:250,000) and 50 mcg.(l:2,000, 
000) respectively. Histamine and acidified epinephrine solutions were 
prepared freshly every two to three weeks and no deterioration could be 
detected. Vials of norepinephrine bitartrate containing 0.1% sodium bisul-
fide as preservative 'I'Tere used, and fresh solutions of acetylcholine chlo-
ride were prepa red daily. 
The adrenergic blocking agents used for this study were all of the 
,'P -haloalkylamine aeries. N-(2-chloroethyl )di benzylamine(Di benamine), N-
ethyl-N-(2-chloroethyl)-benzhydrylamine ( SY-2 ), and N-ethyl-N-(2-chloro-
ethyl)-9-flourenamine ( SY-21 ) have been reported ( 42,57,) to possess 
relatively specific adrenergic blocking activity. 2-(2-biphenylyloxy)-
Table II: The Chemistry and Dosage of the /3-haloalkylamines used in the 
Study of Antagoni sm of Responses of the Guinea Pig Seminal Vesicle to 
Epincphrine ,Norepinephrine,Histamine and Acetyl chol ine. 
Compou.11d Administered Dose / lOOcc . 
H-(2-ehlo~oethyl) dibenzy1amine 5 meg . 
(Dibenamine) 
,/ _ )--:_~\-\? 
- -- . I, 
{ ~-(.\\') 
N- ethyl-N-(2- chloroethy1 )-
benzhydry1amine 
( SY-2 ) 
2-(2-Biphenylyloxy)-2' - ehloro-
t ri e thylamine 
( SY-8 ) 
N- ethyl-N- (2-c:hloroethy1)-9-
flourena.mine 
( SY-21 ) 
/' 
I 1 
..... ,) 
2.5 meg . 
1.25 meg . 
0. 625 meg . 
2. 5 meg . 
1. 25 me€ • 
0. 625 meg . 
0 . _:125 meg. 
8 meg . 
4 meg . 
2 meg . 
1 meg . 
1 meg . 
0.5 meg . 
0 . 25 meg . 
0.125 meg . 
Final Concentration 
1 : 20 , 000 ' 0 00 
1:40, 000 , 000 
1: 80 , 000,000 
1:160 , 000 , 000 
1:40 , 000 , 000 
1:80 , 000 , 000 
1:160 , 000 t 000 
l:J20 , 000 , 000 
1:12,500,000 
1:25' 000 ' 000 
1 :50 , 000 , 000 
1:100 , 000' 000 
1:100 , 000,000 
1 :2000QOO~QOOJ 
1 : 400 ,000,000 
1:800,000 , 000 
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2-chloro-triethylamine ( SY-8 ) has some ability to diminish the depressor 
response to histamine in dogs as determined by Loew (41). It seemed of 
interest to determine the degree of preferential adrenergic antagonism 
these compounds exhibit on the isolated seminal vesicles, and to record 
any evidence of antihistaminic action of SY-8 on smooth muscle in vitro. 
The \:? -chloroethylamines are all '\'Thi te crystalline compounds vri th limited 
solubility in water unless highly acidified. They are relatively unstable 
compounds 'l'lhich deteriorate upon standing or heating, and \vere, thus, 
freshly prepared before each experiment. Four doses of each blocking com-
pound were used, chosen to produce approximately 20%,4o%,6o% and 80% reduc-
tions of the spasmogenic contractions. For the administered doses and final 
concentrations of each compound see Table II. 
For the antagonism studies the following procedure was used. The seminal 
vesicles were allowed to rest for 20 minutes when first inserted into the 
smooth muscle bath, during which period they were washed several times. At 
the end of this interval the appropriate dose of a spasmogen, alternating 
the primary addition between epinephrine and norepinephrine, was injected 
into the bath with a tuberculin syringe. This was left in contact with the 
tissues for one minute \vhile the resulting contraction vras recorded on the 
revolving drum. The kymograph \vas stopped and one minute of v1aahing followed. 
Then, a five minute resti ng period preceded the addition of the second spae-
mogen. This seven minute cycle was repeated until each stimulating drug had 
been administered t1-ri ce, follovling a discrete order. One minute after the 
last spasmogen was washed out, a blocking drug was administered. Four rninutes 
later the first stimulating agent 'I'IaS added for one minute and both drugs 
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were \"lashed out. Thus, the spasmolytic was in contact with the seminal 
vesicles for five minutes. It should be noted that as both the antagonist 
and the spasmogen i-Tere washed put, the following doses of the stimulating 
agents ,.;ere not added in the presence of the antagonizing agent concerned. 
The seven minute cycle wa s again ~epeated until each drug had been added 
t'I'Tice after the blocking action. This whole procedure was carried out on 
eight to ten vesicles for each dose of each antagonistic agent, and each 
experiment took a total of two and a half hours. The control series consisted 
of essentially the same procedure, except that no blocking drug was added 
at any t fume. Thus, eacg spasmogen 'tTas added four times following a prede-
termined order, and the same seven minute cycle as in the antagonism studies 
was used ( see Figure I). 
To evaluate the significance of the blocking activity of each spasmolytic 
a statistical analysis was made. The mean height in millimeters of the first 
two responses of the seminal vesicle to any given spasmogen ( Control ),and 
that of the two responses induced by the stimulating agent following the 
addition of the blocking agent ( Test ) were determined for each experi-
ment. Then, the difference, in percent reduction, between the mean of the 
test responses and tha~ of the control responses was calculated. The mean 
percent reduction for each dose ·. of blocking drug was determined from the 
percent reduction figures for each experiment, and the standard deviations 
computed. Then, the statistical significance and standard error of the mean 
percent reduction for each dose was calculated. The control data from those 
experiments in which no blocking drug was administered was handled in the 
same way ( see Table V ). 
Fi gure I : The Effect of Selec ted 8 - haloalkyl amines on the Responses of the Isol a ted Gui nea 
Pig Seminal Vesicle t o Epinephrine , Norepinephri ne, Hi stamine e.nd Acetyl choline . 
Fi nal Concentrati on of Spas~ogens : N : Norepi nephrine bi t artrate 1:500, 000, E = Epi nephrine 
(base ) 1:500,000 , H = Histamine diphosphate 1: 250, 000, and A~ Acetyl chol ine chloride 1: 2 , 000 , 000. 
Figure IA: Controls,no drug added. Figure IB:1:40,000,000 final concentration of N-(2-chloroethyl) 
dibenzylamifie(Dibenamine) added. Figure IC:l:25,000,000 final concentration of 2-(2-biphenylyl-
oxy)-2'-chloro-triethylamine(SY-8) added. 
The reproducibility of the response of the isolated seminal vesivles 
of the guinea pig to a specified dose of any given spaemogen was also ana-
lyzed. The variation of the response ( see Table III ) was small,keeping 
in mind that the mean variation figures ,.1ere caluulated without regard to 
direction of change. The direction varied, some tissues shOi'led an increase 
in response to the second of the two control additions of spasmogens, and 
an approximately equal number showed a decrease. Thus, it was valid to use 
the mean of the two control responses as a more accurate measure of the 
response of the tissue. 
The ave rage of the two teet responses of the seminal vesicle induced by 
a spasmogenic drug can also be used. A statistical anajyeis revealed that 
there was no significant diff~~ence between the response of the tissue to 
a spasmogen '"~hich was added while the antagonist was in the bath, and that 
elicited by a stimulating drug added after the antagonist was washed out. 
There appeared to be no significant reversal of an established blockade (see 
Table V ). 
A quantitative anajysis of the relative potency of the ~ -haloalkylamines 
employed was also performed. The method for evaluating the potency of a 
drug using dose-response curve data as reported by Bliss ( 9 ) was used. 
Experimental Results 
Seminal Vesicle Activity. 
The untreated seminal vesicle of the guinea pig was normally a quiescent 
organ with little autonomous activity. Only occasionally were spontaneous 
contractions exhibited ru~d these we r e irregular and of smali amplitude. The 
Table III : Reproducibility of Responses of the Isolated Guinea Pig Semina l Vesicle to 
Epinephrine , lifore_9inephrine , Histrunine and. Acetylcholine . 
Spasmogen Number of Contra ctions 
(determined. on number 
of vesic l es) 
Nore1)inephrine 
(b~.se)-
200 mcg .flOOcc. 
Epinephrine 
(base) 
200 mcg . flOOcc. 
Histamine 
d i phosphate 
400 mcg .flOOcc . 
Acetylcholine 
chloride 
50 mcg./lOOcc. 
330 (165) 
330 
(165) 
330 (165) 
256 
(128 ) 
------------
Mean Height in 
millimeters :t. 
standard deviation * 
32.3 ± 10.3 
38 .8 ± 10 .8 
)6.0 -±; 11.8 
~!ean difference 
~ standard deviation + 
4. 4 ;!:. 3 ·~ 
4.8 :±- 4._5 
_5.0 ± 4.2 
6.1 -;!; _5 . 8 
·----- ~ . . . ~- -·~-- ---- -~--
* Hea11 height of designated number of contractions ± S.:EJproximate standard cleviation. 
Standard 
error 
0.28 
0. 3_5 
0. 33 
4.- Nean difference i n millime ters bet\'ll'een tvJO control responses to each sp~ smogen obta i nPd on a sing le 
strip >·ri thout re:sard for o.irect ion of change . The mean 'l!ras computed from a ll ao.di tions of each 
s=9as~ot-:en for a.ll ahta,;;onism studies . 
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addition of t he sympathomimetics, epi nephrine and norepinephrine, to the 
smoot h muscle bath induced a marked contraction of both rhythmically 
active and quiescent organs' see Figure I ). The effect was characterized 
by a quickly rising contraction, with a maintained maximal plateau,and 
a rapid descent with washing. Rhythmical interruptions were seldom seen 
until at the height of the maximal effect for each dose, where t hey appeared 
regularly. The effect produced by the drug persisted as long a s it was 
allowed to remain in contact with the tissue, and rapid relaxation started 
with the washing out of the spasmogen. The contractions pro duced increased 
in magnitude with increased doses of the spasmogen until a maximal height 
was reached. Epinephrine produced consistently greater contractions than 
those induced by equivalent doses of norepinephrine. The mean height in 
millimeters of 330 contractions induced by epinephrine was 38.81 ~ 10.8, 
and that of norepinephrine contractions 32.26 ~ 10.3 ( see Table III ). 
The reactions of the isolated guinea pig seminal vesicle to histamine 
were similar to those to the sympathomimetics. Histamine also produced a 
marked and rapid contraction l'li th rhythmical manifestations only at the 
height of activity. The seminal vesicles were more sensitive to the effects 
of acetylcholine. A marked reaction occurred after the addition of this 
drug in small concentrations, i.e. 50 meg. per 100 cc. Each vesicle immed-
iately contracted to a maximal height 'lvhich v1as not maintained, after 
vrhich a slow relaxation set in without washing . The tendency tovmrds rhyth-
mical interruptions occ~rred only on the downward relaxing slope of the 
tracing, and was usually minimal. The spasmogenic effect remained only as 
long as the stimulating drugs 'l'lere in the bath, and the tissue returned 
.e 
Ta-o l e IV : Re:producibili t ;y of Response of the I sol?... ted Guinea PiP· Semi nal Vesicle to 
Ep i nephrine , Noreyinephri ne , Histamine anrr Acetylcholine . 
Spa smog en 
Norepinephrine 
( ba se ) 
Nuu ber of ]lxperil.nen ts 
200 mcg . /100 cc . 28 
Epine·ohrine 
.. (ba:~e) 
200 mcg. /100 cc . 
Histamine 
di phosphate 
400 mcg./100 cc . 
Ace t ylcholine 
chloride 
50 mcg./100 cc. 
28 
28 
19 
Mean difference ;I;. Standa rd Error* II p II 
'7 o.s 
)0 . _5 
- o. 7 ~ 1.0 0 . 4_5 
- 2.? :1:. 2 . 4 0. 28 
* Mea;-d'iff"er;;;-; in ~illimetersbet;~·;n- the-ir~i tial a.ddi ti~.nd t he fin~l acldi tion of each 
spasmogen mn the Control series . It was computed with due regard for sign: a positive figure 
ind.icates an increase in height of the final contraction ove r t;he initia l contra c tion, A. 
ne:s8.tive figur e indicates a decrease . 
rapidly to a normal state of resting tonus after '\'lashing ( see Figure I). 
The seminal vesicle smooth muscle appears to produce comparable contrac-
tions in response to each specific spasmogen in the doses used. The t\oto 
control responses, before the blocking agent was givffin, were of sufficiently 
equal magnitude to indicate that there was no great variation i n the way 
an individual organ responds to a specific dose of any given drug ( see 
Table III ). The tissue remained reactive for a sufffucient period of time 
for adequate antagonism studies. The addition of the spasmogens readily 
elicited the aforementioned contraction without any significant reduction 
in magnitude or any consistent evidence of fatigue for a period of over 
t 1·1o and one-half hours 1-ti th each pair of organs ( See Table IV ) • 
Some difference in reactivity bet..,.reen guinea pigs and bet....1een individual 
organs was noticed, Vihich may be related to the size or maturity of the 
animal used. Only those contractions measuring greater than 20 mm. we re 
considered to be of sufficient magnitude for accurate evaluation. Although 
not tested for statistical significanee, it 1·1a s found that one out of 
three seminal vesicles of guinea pigs weighing under 450 gms. ( .)00-400grps.) 
reacted 'l'li th contractions measuring less than 20 mm . i n height. I n contrast , 
only one out of five of the organs of animals i•;eighing over 450 gms. ( 450-
600 gms~ were unreactive. Br8.gger ( 12 .J reported a similar i mpression 
from his work with these organs. This may be purely a case of mass of con-
tractile tissue as it appears to be correlated with the length and .-Jeight 
of the organs themsel vee. It was founi that in cases \vhere one vesicle 
was markedly more reactive than its mate under the s~ne conditions, the 
larger seminal vesicle produced a greater contraction in 67% of the cases 
)0. 
studied. Some experimen~ s were carried out early in the series in which 
every organ ivas cut in half, and both ends used at once in the bath. The 
thicker proximal half ivas consistantly more reactive t han the slender 
distal half. Histological studies should be cs.rried out to correlate the 
amount and type of contractile tissue with activity. 
The spasmolytic agents themselves did not exert any noticeable action 
on the smooth muscle of the seminal vesicles. No alteration of tone was 
observed vihen the blocking drugs were added, although occas:ilonally a 
slight enhancement of an existing mfunimal rhythmicity was noted. 
Antagonism Studies. 
All of the ~ -haloalkylarnines used in these experiments significantly 
blocked the response of the isolated seminal vesicles of the guinea. pig 
to epinephrine and norepinephrine. There was some variation on the speci-
ficity of blocking action produced by the individual agents . 
Dibenamine significantly reduced the excitatory response of the vesicles 
to norepinephrine in all doses used. The percent reduction or degree of 
blockade decreased with a decrease i n effective doses of the antagonistic 
agent ( Figure II ). Each dose of Dibenamine administered was l/2 the 
strength of the previous dmse and the respective blockade vias proportion-
ately less pronounced. The same relationship was indicated for epinephrine-
induced responses, although e ach dose of Dibenamine consistently produced 
a lesser degree of reduction of these contractions than those induced by 
norepinephrine ( see Table V ). 
Di benamine reportedly has very v1eak antihistaminic potentialities (57). 
An antihistaminic action was indicated in these studies, as Dibenamine 
['- ~ Q) V"\ t-l (\} (\} v-, V"\ 
•d ~ r-1 (\} 0 (""\ . . . . •rl • • • • 0 0 0 0 
H 0 0 0 0 j I' 
0 • • 
rl () 1-l 
,.q () . 0'\ () {J) ['-
0 C\l '.0 • . 
e Q)O -rt '0 0'\ 0 . • 0 ['-~ r-1 • . (""\ • 0 ['- t-l N rl ori ......_ • (") '.0 • V"\ ('J rl 
o:l rl . rcJ rl ,..; '-0 r-1 -r-f -.-1 
,::: 0 {U) Q) -rl -rl ,....; 
•rl ..c1 t.l r .... +I ""11 -H T-1 ro 
!01 0 s 0'\ \.[) . . (!) rl R.. \1"\ C\l 0'\ 0'\ . . ['- ..:j-
Ul l>. O . . . ['- 0 
+> V"\ § 0 co ro ['- I t11) (!) rl 
•rl () (!) p.., Cl! ;:;;: 
C\l V"\ 
1:1 ['- rl .-I 0'\ 
,::: rl (\} co 0 ,....; 0 r-i 
·rl 0 C"" l 0 C""\ . . • . 
6 Q) ~ . . • . 0 0 0 0 +> 0 0 0 0 C\l . / 
(!) ..c1 . . 
..c1 P; o A 0 +> (/} () . (") q rn r'\ ("" \ • . 
--
no. rn 
Table V : The Antagonism of Selected "' - haloalkyla.mines tm·rards the Res:9onse of the Guinea Pig Seminal 
Vesicle Induced by Various S:ne.smo e;·ens . 
Antagonist 
and 
No . of Norepine:9hrine 
er.ots . 200 meg . base / 100 cc . 
dose /1'00cc. . ¥ 
Neen % red . ±. S. D. llp n 
li!'- ( 2-chlort.iElr~hyl) 
di benzylamine 
(Diben9fil ine ) 
0. 625 meg . ~ 25 .1 -!;. 16. 6 0. 01 
1. 25 meg . 8 41 . 5 -;\; 8 . 4 <0. 01 
2.5 meg . 8 55 -4 ± lJ .1 ' 0. 01 
5 meg. 9 70. 9 ± 11.0 0. 01 
N-e t hyl-N-(2-
ehmoroethy1 ) 
b enzhydrylE~m ine 
( SY-2 ) 
0. 3125 meg . 7 24. 7 :l.. 14. 3 0.01 
0. 625 meg . 9 53· 4 ;I. 28 . 7 O. OJ 
1. 25 meg . 8 8) . 4 -;i 8 . 7 <0. 01 
2. 5 meg . 9 86 . 4 i. 10. 9 ·o. o1 
Epinephrine 
200 meg~ ba~e / 100 cc . 
Hea.Tl ~ red. :i. S.D. upu 
18.5 :\; 1) . 4 ,Q.Ol 
26. 7 ± e._s ,· o. 01 
48 . 5 ;i: 11. ) ( 0.01 
67 . 2 .:!. 11. 9 . o. 01 
16. 7"1.12. 9 o.ca. 
51.? i 24. 5 0. 01 
84- .o i. 7. 9 <0.01 
88 . 1 i 9· 3 ( 0. 01 
Histrunine diphosphate 
l..J.OO meg . / 100 cc . 
Mei"..Il- 5G red . :± S. D. np 11 
19.6 -i 15 -3 ~ a . 01 
- 0. 9 i. )8.4 0. ) 
9 3 :t 9·7 0.02 
6. 7 .:!. 15 .'7 0. )8 
5· 6 "± 6. 9 0.07 
6.1 - 13-3 0.11 
-
19 -3 ;l; 18. 0 0.015 
l O. J .l 18.) 0. 19 
Acetyl chol ine chloride 
50 meg . / 100 cc . 
Mean % red • .:i S.D. np11 
10.5 :i. 1) . 6 0. 15 
8 . 2 16. 9 0.2 
8.9 -;i 6. 3 0.01 
7· 9.:!. 15 . 0 0. 32 
7· 9 l. 20 . 2 0. 27 
0. 6 ;l; 17 . 6 'i 0. 5 
- 7 . 1 :1. 10. 9 . 0. 25 
4 . 8 ::!. 27 -7 1 0 • ._5 
Table V : Continued. 
A..r1tagonist 
and do se 
per 100 cc . 
Uo. of 
erpts 
2-( 2-biphenyl-
y1oxy)-2 1-
ch1oro-triethy1-
amine ( SY-8 ) 
1 meg . 
2 meg . 
8 
8 
4 meg . 10 
8 meg . 7 
1T- ethy1-H-
(2- ch1oroethy1 )-
9-f1ourenamine 
( SY- 21 ) 
0. 125 meg . 10 
e.25 meg . 9 
0.5 meg . 8 
1.0 meg . 9 
Controls 
No drug 28 
x·orepinephrine 
200 meg . bas-~/100cc . 
lvieru1 % red . *;;~;. S. D. npu 
21. 1 ± 15 . 8 LO. Ol 
46 . 7 ;t. 15 . 2 ('0. 01 
67 . 4 i. 12. 3 <0.01 
83 . 2 ± 9· 9 ( 0. 01 
20 . 2 ± 25 . 4 0. 07 
29 . 2 .:. 19 . 4 <0.01 
53· 8 io 17 -2 (0 . 01 
76. 1 ±. 13 . 2 (0 . 01 
2.04 ± 17 . 7 0. 38 
Eni neuhrine 
200 ~cg . ~ase l 100cc . 
A * r ean ~J red . ;. S. D. npu 
18 . 2 ± 11.3 -' 0. 01 
32 . 9 :t 8 .1 <0. 01 
51.5 ;t 22. 8 / 0.01 
77 . 1 :!:. 14. 0 ( 0.01 
18. 3 - 17 . Lr- 0. 013 
29 . 0 :1:. 21.4 l.. O. Ol 
J8 . 7 t. 16 . 7 <0. 01 
66. 9 ±. 14. 0 (0 . 01 
1. 4 ± 16. 9 0.5 
Histamine d_iuhos·ohhee 
400 meg . I ioo ;c. 
H c-1 a* ... I Nean '" re • _. S. D. 1p11 
21. 2 t. 20 . 2 0 . 01 
19. 5 ± 12. 0 ( 0. 01 
32 . 4 :t 12. 9 <0. 01 
48 . 7 ± 17 .0 0. 01 
2. 6 ;t 19 . 0 0.,5 
lO . J "±. 5 · 3 < 0. 01 
10 . 2 i. 12. 9 <o. o4 
14. 7 ;t 12. 0 <0. 01 
3-1 ;i 10 .0 0. 2 
Acetylcholine chloride 
50 meg . I 100 cc. 
viea..11 7~ red~ .± S .D. upu 
15.1 .;!: 7 . 8 <0 . 61 
9. 61 ± 8. 6 0 . 04 
- 7. 6 ± 19. 3 0. 45 
- 3· .5 'i 8.1 ) 0 • .5 
1.9 : 18 . 6 
,... z, ~ 2"- 9 L, . y -- .,.. . 0.5 
* n;-te:;;;;ined f;o:~- the·-~nea;- height- i~ ~illimet;;s -;[2 test~;~-sponses obta:i"n-e-c:f'"A.:r t er.the antagoni-st bad been adde·i to-
the bath, as com:pFtred. "Ii th the avert",ge of 2 of their respect ive control#responses , i n terms of :per cent reduction 
of the control value ± sta.nddrd devi at ion. 
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occasionally blocked the histamine-induced contractions of the seminal 
ve si ole, but the most significant reduction of the contractions \'las seen 
only with the lm.,rest doses of the blocking agent. The higher doses shO\'i'ed 
no comparable reduction ( except for the 1:40,000,000 dose) and eben a 
potentiation of histaminic response follo,.;ed the administration of the 
highest dose of Di benamine. A fe\-r of the kymograph recording s of the antag-
onism cif this dose of Di benamine to'trard histamine sho1t1ed a progressive 
dearease in the histaminic responses themselves, including the two control 
contractions. Thus, the significant feduction found here may be a result 
of the histamine used or the peculiarity of these tissues rather than the 
blocking activity of Dibenamine. The high standard deviations of both the 
1:40,000,000 and 1:16o,OOO,OOO doses may also account for this phenomenon 
and the conclusion that Dibenamine is an effective antihistaminic on the 
basis of these few experiments is not warranted. 
The 1:40,000,000 dose of Dibenamine diminished significantly the con-
traction induced by acetylcholine, but this blocking action \'las not con-
firmed by the other doses used. Again, it may not be considered a valid 
result due to the small number of experiments involved. 
N-ethyl-N-(2-chloroethyl)-benzhydrylamine ( SY-2 ) also appears to be 
a relatmvely specific adrenergic blocking agent. It effectively blocked 
the contractions induced by epinephrine and norepinephrine i n all doses 
applied, the per cent reduction increasing with each increase in dosage (see 
Figure II). In contrast , to the action of Dibenamine, SY-2 appears to have 
antagonized the smooth muscle response to epinephrine and norepinephrine 
to an equivalent degree. 
)2. 
The action of histamine on the isolated seminal vesicles was not 
significantly antagonized by SY-2. The contractions of the organs by 
histamine in experiments 'o'lhere 1:40,000,000 dose of SY-2 'o'Jas administered 
appear to have been significantly potentiated by the adrenergic blocking 
drug. The other doses of the agent do not subt tantiate this indication, 
and the control contractiom' in this series were of slight magnitude so 
that any degree of change would result in unwarranted values. The indica-
tion of histamine potentiation appears to be due primarily to chance re-
action of the tissues to histamine, rather than a significant property 
of SY-2. The excitatory responses of the seminal vesicles to acetylcholine 
\'lere not significantly altered by SY-2. 
The biphenylyloxy member of the ' · -chloroethylamines ( SY-8 ) , exhibited 
a marked ability to block the response of the seminal vesicles to epine-
phrine, norepinephrine and histamine in all doses administered. The block-
ing agent reduced the norepinephrine -induced contractions most pronouncedly, 
those produced by epinephrine to a lesser degree, and the histaminic con-
tractions minimally, but the per cent reductions for all doses against 
all three spasmogens were highly significant (see Table V ). An increase 
in blockade paralleled an increase in applied dose of the antagonizing 
agent(see Figure II). Thus, SY-8 st~Dds out as a consistent and effective 
antihistamine compound, as well as an adequate adrenergic blocking agent 
as herein tested. 
Curiously, SY-8 in doses of 8 mcg./lOOcc. and 1 mcg./100 cc., also 
effectively blocked the contractions produced by acetylcholine. Prepara-
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Figure II : Dose-response Rela tionship of the Antagonism of Epi nephrine and Nore inephri ne-
induced 6:9asm of the Isolated Guinea Pig Ser::linal Vesicle by Aryl-halo-e,l kyl amines . 

tiona of this spasmogen were not always available for the experiments 
using the tvlO middle doses of SY-8 and the data are not sufficient in 
quantity for evaluation. It is difficult here ttil determine whether any 
conclusion concerning an atropine-like quality of SY-8 is valid. 
N-ethyl-N-(2-chloroethyl)-9-flourenamine ( SY-21 ) appears to be a 
most potent adrenergic blocking agent. It effectively blocked the action 
of norepinephrine on the seminal vesicles in the three highest doses used, 
which in turn were less than the doses of the other ~-haloalkylamines 
applied. Norepinephrine was significantly blocked by l:lOO,OOO,OOO, 1:200, 
000,000 and 1:4oo,ooo,ooo final concentrations of SY-21, but 1:80QOOO,OOO 
proved to be a subminimal dose. The antagoni am tOl'larda norepinephrine was 
more pronounced than that towards epinephrine, although the epinephrine-
induced responses were significantly blocked in all doses used. 
SY-21 appears to possess antihistaminic potentialities. In final con-
centrations of l:lOO,OOO,OOO and 1:200,000,000 and 1:4oo,ooo,ooo, the 
compound effectively blocked the response of the seminal vesicles produced 
by histamine, but 1:8oO,OOO,OOO did not produce a significant diminution 
of the contraction. The per eent reduction was of almost equal magnitude 
for each effective dose and alway~ much less than that exhibited by the 
blocldng action against the sympathetic responses. There was a significant 
increase in the histamhne blockade, or decsease in the height of the con-
traction induced by the second dose of histamine after the tissue had been 
exposed to SY-21. This might indicate a latent period for blocking action 
against histamine, but it is not a valid conclusion. The control responses 
themsfJ.l ves sho,'!ed a significant decrease in the height of contraction due 
to the fourth addition of histamine as compared to the response to the 
third application. Thus,either the sensitivity of the tissue to histamine 
activity or the potency of the histamine solution itself \'Tas diminished. 
SY-21 did not effectively alter the excitatory action of acetylcholine 
on the guinea pig seminal vesicle and no significant evidence of rever-
sibility was found in regard to the blockade pr oduced against the contrac-
tions due to norepinephrine, epinephrine and histamine. 
The blocking action of Dibenamine and SY-2 against the responses of 
the organs due to epinephrine and norepinephrine was not diminished or 
reversed by \vashing the tissue and removing the spasmolyti u from the nut-
rient fluid. Repeated doses of the sympathomimetics did not produce an 
increase in magnitude of contraction once the blocking agent had been ad-
mini stared. In each experiment either epinephrine or norepinephrine \vas 
added with the spasmolyti u in the bath as the first stimulating agent 
after the blockade was established. Then each was added later in its turn 
in the repeat of the aerie a. Thus, there were always four \'lashings between 
each addition of each spasmogen. A statistical analysis by paired data. 
indicates that there was no significant difference bet\·reen the first addi-
tion of epinephrine or norepinephrine after the blocking agent was applied 
and the second addition four washings later( see Table VI ). 
The blocking action of SY-8 against the response of the guinea pig 
seminal vesicle to all four spasmogens was also not washed out or overcome 
by additional applications of the stimulating agents, since the reversibi-
lity evaluation yielded no significan~ increase in height of contractions 
induced by the second additions of each spasmogen. 
Table VI: Reversibilit.y of the :Blocking Effect Procluced by Selectecl0 -haloe~lkylamines against the 
Resfonse of the Isola.ted Guinea Pig Se:ninal Vesicle Induced_ by Various Spasmogens . 
.Antagonist 
Number of 
Experiments 
N- (2-chloro-
ethyl )d.iben-
zylamue 
(Dibenemine) 19 
N- ethyl-N- (2-
chloroethyl) 
benzhyd.rylamine 
( SY-2 ) 17 
2-(2- biphenylyl-
oxy- 21-chloro-
triethylamine 
( SY-8 ) 17 
N-ethyl- U-(2-
chloroethyl)-9-
flourenamine 
( SY-21 ) 16 
Controls 
No antagonist 
aG.d.ed. 28 
Norep inephrine bita rtrate 
200 mcg . of baseJlOO cc . 
l·fean difference 
± standard. error* 
l.J. ;± 0-9.5 
- 1. 4 ;t 1.3 
1 . 0 + 0 . 6 
- 0.7 1 . 6 
0. 2,5 
0 . 2,5 
> 0 • . 5 
0 . 2,5 
-,o .s 
Epinephrine hydrochloride 
2oo mcg . of base/100 cc. 
J:Tumber of 
Experiments 
14 
18 
13 
18 
28 
Mean difference 
~ standard. error* 
- 1.4:! 1.3 
0 . ,5 ± 0.8 
0. 3 !: 0. 6 
0 . 6 :1:: 0 . ,5 
0.2 
0 . 1 
)0 . ,5 
) 0 . ,5 
0 . 2 
* The difference beh.reen the test response obtained in the presence of the antagonist , a..r1c1 the test repponse 
obtainec1 afte r the antagonist had l)een removed by four •~ashin.gs, in millimeters ± standard error . 
+ npu is proba.biUty , sigmificarrt if less tba ... 't'l 0.0,5. 
The blocking responses to epinephrine and norepinephrine induced by 
SY-21 also showed no indication of being reversible. The SY-21 blockade 
of histamine activity was significantly increased, but as pointed out above, 
the control data also showed a significant increase in the response of 
the f inal addition of histamine over that of t he initi al addition, and 
true reversibility of blockade La not necessarily indicated. 
The potency evaluation based mn the dose response relationship of adren-
ergic blocking activity revealed that SY-2 and SY-21 are the mo st potent 
adrenergic blocking agents of the series studied ( see Table VII ). The 
En50 , as the dose in micrograms of the antagonist which produces a 50% 
reduction in the response of the seminal vesicles to a spasmogen, compared 
wlilth the controls, in 50% of the trials, is a measure of the comparative 
potency of the series of blocldng drugs. The lower the ED50 dose the more 
potent the agent is. The 95% confidence limits indicate the range of ED50 
values 'v'Thich "r/ould be obtained in 95 out of 100 trials. These figures are 
also an eualuation of the significance of the differences in the ED50 values. 
If the figures for the confidence limits of one drug overlap those for 
another drug, then there is no significant difference in potency between 
these tv1o drugs. Likevlise, if they do not overlap and the ED50 doses do not 
fall within the same range, the difference in potency is significant. In 
this study it is seen that SY-2 and SY-21 have the smallest ED50 values and 
thus,are more potent adrenergic blocking agents than Dibenamine or SY-8, 
whose ED50 values are considerably larger. The 95% confidence limits of SY-2 
and SY-21 overlap and thus, they appear to be of comparable potency. This is 
also true for SY-8 and Dibenamine Hhich have comparable 95% confidence limits. 
Table VII: The Relative Potency Eval uation of the Ability of Selected - halaallcylamines to Inhibit 
the Response of Isolated Guinea Pig Seminal Vesicles to Epineplj..rine and Norepinephrine . 
Antagonist Epinephrine hyclrochlo ri<le Nore-pinephrine bitartrate 
200 mcg .of base/100 200 mcg .of base/100 
N-(2-chloroethyl) 
d.i benzylemmme 
(Di bena.mine) 
N-ethy1-lJ-
(2- ch1oroethyl)-· 
benzhyctrylamine 
( SY-2 ) 
2-(2- b i phenylyl-
oxy)- 2 1-chloro-
triethyh"t.mine 
b ±. S. D.* 
55 .87 "j; 5·83 
111.68 :. 13.89 
( SY-8 ) 64.08 i 8 . 48 
N- ethyl-N-
(2-ch1oroethyl)-
9-flourenamine 
( SY-21 ) 51.61 ~ 8 . 60 
lambd.a+ 
0.205 
0.155 
0. 343 
cc . cc . 
ED SO ( 9.55bC. I •• ); b t S .D. * lambclat 
2.6 (2 .2 to 3 .2) 50 .25 ± 6. 24 0.241 
0.59 (o.L~9 to o. 73) 98.19 ±. 17.23 0 . 204 
3 . 4 (2 . 8 to 4 . 2) 69.34 t 7.28 0.195 
0.59 (0.42 to 0.84) 63 . 37 ~ 9.54 0. )09 
4-
ED 50 ( 95%c.r .• ).,. 
1.9 (1 . 6 t o 2.3) 
0 . 57 (0.46 to 0.70) 
2. 4 (2.1 to 2 .8) 
0.43 (0 . 33 to 0 • .55) 
a Regression 6oefficient plus or minus stand.arcl deviation. 
,_ Total variation (eJo..-pressed as stand.ard. deviation) of the original data on 11hich the reg ression coefficient 
\·tas based ,div ided by b. Less than 0 . 30 is sufficient f or reliability. 
; The doae in meg . of t he antagonist uhich :oroduces a 50~; reduction of response to the spasmog en, compared 
1-ri th control s. 95% confidence limits in parentheses indica te the range of ED 50 values \·Thich i·JOulcl be 
obtained in 95 out of 100 similar experiments . 
The ED50 range of values for these pairs of adrenergic blocking compounds 
are \<lidely separated, and the 95% comfidence limits do not overlap. Thus, 
SY-2 and SY-21 show significantly greater potency as adrenergic blocking 
agents than do SY-8 and Dibenamine. 
The sensitivity of the action of a drug or agent on a tissue can be 
determined by the regression coefficient. The regression coefficient mea-
sures the rate of increase of the per cent reduction per unit increase 
of dose, and is actually an average slope of the dose response curve de-
rived by consideration of all points along the line. A large regression 
coefficient expresses a great sensitivity to a drug, and a smaller incre-
ment in dosage of drug required to produce a unit change in reponae. This 
may also be express ed graphically, as the steeper the slope of the dose 
re~ponse curve the greater the sensitivity. For detailed discussion and 
information concerning the mathematics and formulae involved in this potency 
and regression coefficient evaluation, the article by Bliss should be con-
sulted ( 9 ). 
The regression coefficient of SY-2 is considerably larger and the slope 
of the dose response curve steeper ( see Figure II ) than tho se of the 
other antagonists tested. This indicates that SY-2 manifests greater sensi-
tivity and that smaller increments in the dosage of the drug will produee 
greater ch~~ge e in the reeponses(Table VII). · 
The value,lambda,expresses the reliability of the estimate, and is 
dependant on the variation of the original data upon ,,·hi ch the regre asian 
line is drawn,and the slope determined by the regression coefficient. The 
lower the value of lambda the more reliable is the estimate. A relatively 
low figure for lambda was sho\>m for all the antagonism studies except those 
using SY-21, and this larger value resulted from the considerable variation 
bet\>Teen guinea pigs ( Table VII ) • 
No quantitative potency evaluation could be successfully made for any 
antihistamine or anti-acetylcholine activity of these drugs because no 
adequate dose response relationship was obtained . The histamine and acetyl-
choline nlockades indicated in these studies are all of similar magnitude 
regardless of doses, and the results reported are thus only qualitative. 
Discussion 
All of the selected ~ -haloalkylamines successfully antagonized the res-
ponse of the guinea pig seminal vesicles to epinephrine and norepinephrine. 
The blockade \'las adequately established within the time allowed for the 
antagonizing drugs to be in contact \'lith the tissue. The relatively long 
period of exposure of the tissue to the blocking agents seemed to be re-
quired in vie\v of the theory of Nickerson (57) of the slo\·t, two-step dev-
elop~ent of the non-equilibrium type of blockade produced by these. agents. 
The fact that the antagonism produced by the -haloalkylamines \·rae mani-
fest even if the drug \·taB washed from the bath indicates that the drugs \vere 
firmly fixed to the tissue. The seminal vesicles still reacted to acetyl-
choline in most cases, so the lack of reaction to epinephrine, norepine-
phrine and histamine was not due to the di sruption of the contractile mechan-
ism of the tissue. Rather a selective action on receptors.upon which the 
sympathomimetics and histamine acted t~ produce a contraction is suggested. 
38. 
Di benamine, SY-8 and SY-21 di minished t he contractions induced by. nor-
epinephrine to a greater degree than t hat produced by epinephrine. This 
observation has also been re ported by Tripod and Meier (79) from their 
studies of the blocking activity by various types of adrenergic blocking 
agents of the responses of the guinea pig seminal vesicle i nduced by epi-
nephrine and norepinephrine. This does not necessarily indicate a greater 
antagonism of t hese drugs towards norepinephrine. Epinephrine consistently 
produced a greater initial contra ction of the smooth muscle than did an 
equivalent dose of norepinephrine. Thus, a smaller actual reduction of 
t he norepinephrine response woul d result in a higher per cent reduction. 
It could actually be the case, however, that these three ~ -chloroethyl­
amines do sho'l'r a preferential ant agonism towards norepinephrine. The control 
contractions to epinephrine are more pronounced in the SY-2 series a lso, ~~d 
yet this drug blocks both sympathomimetics to a comparable degree' see Table 
: V). The potency evaluation also shows some difference in the ED50 valu es 
of SY-2 required to block t he effect s of the t wo spasmogens. However, the 
95% confidence limits of the epi nephrine and norepinep0-rine fig~res all 
overl ap ru1d the difference is not signi f icant(see Table VII). 
The contractions of the seminal vesicles caused by histamine ,.,ere blocked 
signi f icantly and consistently by SY-8 and SY-21. SY-8 has been shovm pre-
viously (41,59) to exhibit antihistamine tendencies, and is considered a 
non-specifi_c member of t he 13 -haloalkylamine series. SY-21, on the ether 
hand, has been reported to be a potent,but also specific, adrenergic blo ck-
ing agent (31,42), vlhich is in contrast to the results reported here. Hista-
mine re sponses were consistently blocked by SY-21 in all doses but the smallest, 
and the control data indicates no significant persistant spontaneous reduct-
ion of the histamine-induced response of the _tissue. Ho'>'rever, the standard 
deviation of the mean per cent reduction and the standard error \•Iere not 
small,and this phenomenon may be valid only within the limits of this experi-
ment. 
The antihistamine function of t he P -haloalkylamines does not necessarily 
parallel the adrenergic blocking activity. SY-8 appears to be comparable 
to Dibenamine in sympathomimetic blocking ability, but is the most potent 
antihistaminic of the (? -chloroeth~lamines studied here. Nickerson (59) 
reports that this histamine blockade is similar to t hat produced against the 
sympathetic nervous mediators. It presumably develops in two stages, the 
first involving a competitive equilibrium vlith histamine, \'l'hich is no longer 
present after the compl etion of the blocking action. Competitive inhibition 
of this blockade by Benadryl indicates that there may be a common site of 
action (59). 
The responses of the isolated organs to acetylcholine \vere not signi-
ficantly antagonized by Dibenamine, SY-2, or SY-21. Anticholinergic properties 
are reportedly found independent of antihistaminic aotivity (59),but SY-8 
produces a blockade against the effects of both of t hese stimulating agents. 
Atropine-like activity v1as indicated by SY-8 in these experiments as both the 
highest and lov;est doses of the drug significantly reduced the acetylcholine-
induced responses of the seminal vesicles. It should be noted,however, that 
acetylcholine induced the greatest amount of variability in responses in 
the control series( Table III and Table IV). Suffieient data are not available 
for an adequate range of dJoses, but it "10uld appe_ar that under the specified 
conditions of this experiment SY-8 exhibits anti-acetylcholine potentialities. 
40. 
The potency evaluation revealed that SY-2 and SY-21 are the most 
potent blocking agents of the four compounds investigated. These two agents 
exhibit a comparable magnitude of blocking ability against norepinephrine 
and epinephrine( Table VII). SY-8 and Dibenamine also share a comparable 
range of potency values, although this pair of drugs is considerably lese 
active as adrenergic blocking agents than SY-2 and SY-21. The large regression 
coefficient of SY-2 ( see Table VII) indicates a great sensitivity of the 
tissue to this drug, and thus, a small increase in the dose of the drug 
would be required to produce a change in the response of the vesicles. The 
regression coefficient of the other three antagonists show a comparable 
degree of sensitivity of action of these agents, which in turn is much 
less than that of SY-2. This is not consistant with the report made by 
Loew ( 42 ) concerning studies on the blood pressure reversal in dogs, in 
which it was suggested that SY-21 was ten to twenty times more potent an 
adrenergic blocking agent than SY-2. The potency of SY-2 determined on 
the guinea pig seminal vesicle may only be accurate for this isolated tissue. 
The lambda values for all of the drugs except SY-21 are of small enough 
magnitude to indicate that the estimate of potency for these agents in 
~ 
t hese experiments is reliable within limits. The SY-21 daia produce a larger 
figure for lambda than is considered desirable, and t hesa data may not, 
therefore, be entirely reliable. As lambda is calculated from the total 
variance of the original data divided by the regression ceefficient, the 
value of lambda may be decreased by smaller variations of the dose-response 
data, which may be a faator dependent upon qualities of the tissue chosen 
for the antagonism studies. An increase in regression coefficient values 
due to a greater number of experiments upon which the data and estimate 
are based may also serve to decrease the lambtia figures. 
The seminal vesivlee of the guinea pig appear to be reaso~ably suitable 
test objects for this type of dose response study. They exhibit definite 
contractions to the four spasmogens used in this experiment vrhich were 
of adequate magnitude for accurate measurement. There is some variation 
in the sensitivity of individual seminal vesicles to the spasmogens and 
adrenergic blocking agents, eo large numbers of organs should be used to 
achieve small standard deviations and reliable estimations of potency. 
The rhythmicity which consistantly appears at the height of the contraction 
is not desirable for quantitative studies, but otherwise little inherent 
activity is manifested to complicate evaluations of results. The seminal 
vesicles of the guinea pig remain active for sufficient periods of time 
for experimental i"lOrk '·ri thout marked indications of fatigue or changes 
in sensitivity to stimulating agents. These organs appear to be easily 
adaptable to antagonism studies, and are recommemded f or experiments of 
this type. 
Summary 
The responses of the isolated seminal vesicles of t he guinea pig due 
to epinephrine, norepinephrine, histamine, and acetylcholine v1ere investigated. 
These agents all induced a marked contraction of these tissues which was 
reproducible end suitable for qualitative and quantitative antagonism studies. 
The preferential adrenergic, histaminic, and cholinergic blocking action 
of selected ~ -haloalkylam.ines was studied. 
A quantitative potency evaluation of the c9mparative magnitude of activity 
of N-(2-chloroethyl) dibenzylam.ine (Dibenam.ine), N-ethyl- N-(2-chloroethyl)-
benzhydryl amine ( SY-2), 2-(2-biphenylyloxy)-2 1-chloro-triethylamine (SY-8), 
and N-ethyl-N-(2-chlo~oethyl)-9-flourenam.ine (SY-21) was performed. 
SY-2 and SY-21 exhibit a comparable degree of a ctivity and vlere the most 
potent adrenergic blocldng drugs of the f our agents tested. SY-8 and Diben-
amine produced adrenergic blockades of the same range of magnitude, and 
were considerably less potent than SY-2 and SY-21 . 
SY-2 appears to be the most specific of the potent adrenergic blocking 
agents used as no consistent reduction of responses induced by histamine or 
acetylcholine was noted. 
Dibenam.ine was comparatively specific in action, but of limited effect-
iveness concerning antisympathetic activity. 
SY-21 exhibited potent adrenergic blocking ability, but also potential 
anti histaminic ac'ti vi ty which decreases its specificity . 
SY-8 possessed limited ability as an adrenergic blocking agent, and was 
highly non-specific due to consistent antihistaminic and potential anti-
cholinergic activity . 
i. 
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